Cargando…

Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study

BACKGROUND: Involuntary weight loss (IWL) is frequent in advanced cancer patients causing compromised anticancer treatment outcomes and function. Cancer cachexia is influenced by nutrition impact symptoms (NIS). The aim of this study was to explore the frequency of NIS in advanced patients and to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Omlin, Aurelius, Blum, David, Wierecky, Jan, Haile, Sarah R., Ottery, Faith D., Strasser, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581613/
https://www.ncbi.nlm.nih.gov/pubmed/23307589
http://dx.doi.org/10.1007/s13539-012-0099-x
_version_ 1782260449003175936
author Omlin, Aurelius
Blum, David
Wierecky, Jan
Haile, Sarah R.
Ottery, Faith D.
Strasser, Florian
author_facet Omlin, Aurelius
Blum, David
Wierecky, Jan
Haile, Sarah R.
Ottery, Faith D.
Strasser, Florian
author_sort Omlin, Aurelius
collection PubMed
description BACKGROUND: Involuntary weight loss (IWL) is frequent in advanced cancer patients causing compromised anticancer treatment outcomes and function. Cancer cachexia is influenced by nutrition impact symptoms (NIS). The aim of this study was to explore the frequency of NIS in advanced patients and to assess specific interventions guided by a 12-item NIS checklist. METHODS: Consecutive patients from an outpatient nutrition-fatigue clinic completed the NIS checklist. The NIS checklist was developed based on literature review and multiprofessional clinical expert consensus. Chart review was performed to detect defined NIS typical interventions. Oncology outpatients not seen in the nutrition-fatigue clinic were matched for age, sex, and tumor to serve as controls. RESULTS: In 52 nutrition-fatigue clinic patients, a mixed cancer population [IWL in 2 months 5.96 % (mean)], the five most frequent NIS were taste and smell alterations 27 %, constipation 19 %, abdominal pain 14 %, dysphagia 12 %, and epigastric pain 10 %. A statistically significant difference for NIS typical interventions in patients with taste and smell alterations (p = 0.04), constipation (p = 0.01), pain (p = 0.0001), and fatigue (p = 0.0004) were found compared to the control population [mixed cancer, 3.53 % IWL in 2 months (mean)]. CONCLUSION: NIS are common in advanced cancer patients. The NIS checklist can guide therapeutic nutrition-targeted interventions. The awareness for NIS will likely evoke more research in assessment, impact, and treatment.
format Online
Article
Text
id pubmed-3581613
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35816132013-03-01 Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study Omlin, Aurelius Blum, David Wierecky, Jan Haile, Sarah R. Ottery, Faith D. Strasser, Florian J Cachexia Sarcopenia Muscle Original Article BACKGROUND: Involuntary weight loss (IWL) is frequent in advanced cancer patients causing compromised anticancer treatment outcomes and function. Cancer cachexia is influenced by nutrition impact symptoms (NIS). The aim of this study was to explore the frequency of NIS in advanced patients and to assess specific interventions guided by a 12-item NIS checklist. METHODS: Consecutive patients from an outpatient nutrition-fatigue clinic completed the NIS checklist. The NIS checklist was developed based on literature review and multiprofessional clinical expert consensus. Chart review was performed to detect defined NIS typical interventions. Oncology outpatients not seen in the nutrition-fatigue clinic were matched for age, sex, and tumor to serve as controls. RESULTS: In 52 nutrition-fatigue clinic patients, a mixed cancer population [IWL in 2 months 5.96 % (mean)], the five most frequent NIS were taste and smell alterations 27 %, constipation 19 %, abdominal pain 14 %, dysphagia 12 %, and epigastric pain 10 %. A statistically significant difference for NIS typical interventions in patients with taste and smell alterations (p = 0.04), constipation (p = 0.01), pain (p = 0.0001), and fatigue (p = 0.0004) were found compared to the control population [mixed cancer, 3.53 % IWL in 2 months (mean)]. CONCLUSION: NIS are common in advanced cancer patients. The NIS checklist can guide therapeutic nutrition-targeted interventions. The awareness for NIS will likely evoke more research in assessment, impact, and treatment. Springer-Verlag 2013-01-11 2013-03 /pmc/articles/PMC3581613/ /pubmed/23307589 http://dx.doi.org/10.1007/s13539-012-0099-x Text en © Springer-Verlag Berlin Heidelberg 2013
spellingShingle Original Article
Omlin, Aurelius
Blum, David
Wierecky, Jan
Haile, Sarah R.
Ottery, Faith D.
Strasser, Florian
Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title_full Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title_fullStr Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title_full_unstemmed Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title_short Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
title_sort nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581613/
https://www.ncbi.nlm.nih.gov/pubmed/23307589
http://dx.doi.org/10.1007/s13539-012-0099-x
work_keys_str_mv AT omlinaurelius nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy
AT blumdavid nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy
AT wiereckyjan nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy
AT hailesarahr nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy
AT otteryfaithd nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy
AT strasserflorian nutritionimpactsymptomsinadvancedcancerpatientsfrequencyandspecificinterventionsacasecontrolstudy